Open4.430 | Close- |
Vol / Avg.78.392K / 1.512M | Mkt Cap673.193M |
Day Range4.430 - 4.630 | 52 Wk Range2.605 - 10.790 |
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
08/02/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $207.17M | Get Alert |
05/03/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $208.52M | Get Alert |
02/14/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $218.31M | Get Alert |
11/03/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $190.00M | $187.45M | Get Alert |
08/03/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $187.62M | Get Alert |
05/04/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $189.38M | Get Alert |
02/15/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $191.87M | Get Alert |
01/10/2022 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $153.00M | $154.00M | $153.10M | Get Alert |
11/03/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $148.00M | $155.00M | $152.70M | Get Alert |
08/04/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $148.00M | $155.00M | $150.16M | Get Alert |
05/05/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $145.00M | $155.00M | $149.93M | Get Alert |
02/24/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $145.00M | $155.00M | $159.15M | Get Alert |
07/16/2020 | ADPT | Adaptive Biotechnologies | Q2 | 2020 | — | — | — | $20.00M | $20.50M | $18.38M | Get Alert |
01/21/2020 | ADPT | Adaptive Biotechnologies | FY | 2019 | — | — | — | $84.00M | $85.00M | $82.76M | Get Alert |
There have been no specific sales or earnings guidance reported for Adaptive Biotechnologies in recent months.
Browse guidance and forecast on all stocks.